In the wake of the sweeping ebola virus of 2014 in Africa ten thousand innocent children have lost either one or both parents. These survivors of this deadly pandemic are left to live in confusion and uncertainty. Stigmatized by the fear that they can infect others, they’re left isolated, with no relatives or surviving adults to care for them. Psychologically damaged and without food or care these little ones are facing a dark future.

Imagine for a moment that you are the only surviving member of your family. Imagine the aftermath of witnessing the horrific deaths of many members of the community you grew up in; many of whom were the only faces you have known; many of whom were the only family you have in this world. Imagine the loneliness, fear and anxiety of not knowing what tomorrow holds, of not feeling cared for, accepted or even wanted by anyone. This is the reality of an Ebola orphan.

Africa Day was on March 25^th 2015. The day has just passed and many interesting things were said by African and world leaders. Africa has had it’s ups and downs this year, from such things as devastating as the Ebola Crisis to a growing middle class. Africa has seen great triumphs and great losses this year. But, what will be remembered the most? Will it be social advances that stand out, economic advances, or devastation caused by disease?

Despite Africa’s beautiful sunsets and landscapes, many Africans are depressed. Depression is feeling of despondency and is a hurtful factor for the development of countries. Economic prosperity is good, but pointless with out happiness. Sadly, depression is wide spread throughout the world, but seems to be centralized around Africa. Happiness levels can affect ambitions, virtues, and health. Love and happiness is what people live for and to see it stolen from war, greed and ignorance is truly despairing.  

The Ebola outbreak of 2014, declared a global health emergency, has finally shown signs of slowing down. Children who fell victim to the crisis, however, are continuing to become orphaned due to the loss of family.

A recent article made a convincing case for the usefulness that microfinance might offer in West Africa. Travel restrictions and program freezes put much local investment on hold during the Ebola outbreak but not that things are calming back down, there is need for investment; both for routine infrastructure improvements and a healthcare system that is prepared in the unfortunate case of a future outbreak.

Governments in African countries such as Rwanda, Swaziland, Sierra Leone and Ghana are reporting reduced malaria mortality rates due to a collective effort to control the disease. A mix of preventive measures are now widely used by trained community health workers equipped with test-kits, freely distributed mosquito-nets, and anti-malaria drugs - as well as the use of anti-malaria awareness public health campaigns.

We are delighted to be doing our own part in helping to reduce the incidence of malaria.

In 2014, Ebola took the world by surprise.

The outbreak of the deadly virus, starting first in Guinea and moving through Sierra Leone, Liberia, Nigeria, Mali and even the US and the UK, has been a reality check for the whole world. As developing countries struggled to contain the virus, developed nations realized they weren't so ready to tackle this hydra-headed monster either.

The numbers alone are shocking:  The World Health Organization (WHO) estimates that over 20,000 people battled the Ebola virus in 2014 and 8,000 died. 

"The number of mosquito-caused deaths really is a mind-blowing thing.

Serum therapy is broadly defined as the act of transferring certain humoral antibodies from an animal proved to have a high concentration of these antibodies to another animal in need of the same antibodies temporarily. The applications of this term is widely used even when other species other than human is the recipient or donor. As part of the solution to many viral diseases there are also probes associated with serum therapy as a whole, those include transmission of other infections other than the target disease.